Cue Biopharma develops injectable treatments that target specific immune cells for autoimmune and inflammatory diseases. It last closed at $4.15 on Nov 20, down 7.78% on the day. The next earnings report for CUE is expected around Mon, Mar 15, 2027, after the close. For the quarter ended Sep 2026, CUE reported EPS of -$4.74 on revenue of $132,000, with revenue down 93.9% from a year ago. Over its last 8 reports the stock moved an average of 19.8% the session after earnings. Over the last 12 months CUE insiders bought $100K of stock on the open market and sold $2.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is CUE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CUE.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CUEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CUE · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 284% below its 20 day and 422% below its 50 day average. It is 417% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 25), oversold. The nearest support is the Pivot S1 at $3.83, and the nearest resistance the Pivot at $4.37.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 65.6%/day
Key levels
$45.5052 week high+996.4%
$25.47100 day average+513.7%
$21.6550 day average+421.7%
$21.48200 day average+417.6%
$19.54Swing high (Oct 21)+370.8%
$15.9320 day average+283.9%
$4.68Pivot R1+12.8%
$4.37Pivot+5.3%
$4.15Last close
$3.83Pivot S1−7.7%
$2.8352 week low−31.8%
$2.83Swing low (Nov 17)−31.8%
Indicators
RSI (14)
24.72
Oversold below 30
Oversold
MACD
-4.32
Below its signal line
Bearish
Stochastic
8.9
Near the bottom of its range
Oversold
ADX (14)
26.1
Trending down
Williams %R
-92.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-168.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−77.8%
Change over 10 sessions
Bearish
ATR (14)
$2.72
Typical daily range, 65.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 201.3%/day
Key levels
$45.5052 week high+996.4%
$25.47100 day average+513.7%
$21.6550 day average+421.7%
$21.48200 day average+417.6%
$19.54Swing high (Oct 21)+370.8%
$15.9320 day average+283.9%
$4.68Pivot R1+12.8%
$4.37Pivot+5.3%
$4.15Last close
$3.83Pivot S1−7.7%
$2.8352 week low−31.8%
$2.83Swing low (Nov 17)−31.8%
Indicators
RSI (14)
34.78
Weak, oversold below 30
Neutral
MACD
-2.48
Below its signal line
Bearish
Stochastic
7.0
Near the bottom of its range
Oversold
ADX (14)
31.6
Trending down
Williams %R
-96.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-230.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−85.6%
Change over 10 sessions
Bearish
ATR (14)
$8.35
Typical daily range, 201.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CUE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CUE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CUE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CUEHow many large options trades hit CUE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CUE in the last 90 days.
From SEC Form 4 filings by CUE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CUE is in one of them and how their past CUE trades turned out.
Cue Biopharma is a biopharmaceutical company based in Somerville, Massachusetts, that is developing injectable treatments for autoimmune and inflammatory diseases. Its drug candidates are designed to act on specific immune cells, aiming to calm harmful immune responses while leaving the rest of the immune system largely intact. Its lead program is still in preclinical work, and some of its other candidates have been licensed to outside drugmakers. The company's target patients are people living with these conditions.